BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15

• Press Releases

  enGene Reports Second Quarter 2026 Financial Results and Provides Business Update

  June 15, 2026

   · 

  16 min read
• Press Releases

  Sumitomo Pharma America Announces Encouraging Clinical and Translational Data at EHA 2026, Highlighting Investigational Combination Therapy in Relapsed/Refractory Myelofibrosis and New Research Findings in Menin Inhibition in Leukemia

  June 15, 2026

   · 

  7 min read
• Press Releases

  Wiley and IQVIA Release Cross-Sector Report on AI’s Promise and Pressure Points Across Healthcare Value Chain

  June 15, 2026

   · 

  5 min read
• Press Releases

  Arialys Therapeutics Announces First ANRE Patient Treated with ART5803 in Open-Label Phase 2 Study and FDA Clearance of IND for Randomized Phase 2 Study

  June 15, 2026

   · 

  5 min read
• Press Releases

  Orca Bio Adds East Coast Manufacturing Capacity and Triples West Coast Manufacturing Workforce Ahead of Potential Orca-T® Launch

  June 15, 2026

   · 

  4 min read
• Press Releases

  Cardiawave Announces First Routine Treatments Performed with Valvosoft® Following CE Mark Approval and Accelerates Its Deployment

  June 15, 2026

   · 

  6 min read
• Press Releases

  Applied Biologics Reports Statistically Significant Improvement in Wound Closure Outcomes in Updated Analyses of the CAMPX Randomized Controlled Trial Evaluating XWRAP®

  June 15, 2026

   · 

  4 min read
• Press Releases

  AstraZeneca Joins ZERO Prostate Cancer’s Historic ‘Blitz the Barriers’ Initiative as a Founding Partner

  June 15, 2026

   · 

  3 min read
• Press Releases

  Inhibrx Announces U.S. FDA Acceptance of BLA for Ozekibart in Patients with Conventional Chondrosarcoma

  June 15, 2026

   · 

  10 min read
• Press Releases

  Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs

  June 15, 2026

   · 

  4 min read